Astellas Responds To “Approvable” Letter For Prograf MR Kidney Transplant Claim
This article was originally published in The Pink Sheet Daily
Executive Summary
Tokyo-based pharma is still examining what action to take regarding a “not approvable” letter for a heart transplant indication.